Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Cytoskeletal structures and the mechanics of cell matrix adhesion

Prof Alexander Bershadsky - Weizmann Institute of Science, Rehovot, Israel
Cytoskeletal structures and the mechanics of cell matrix adhesion ( Prof Alexander Bershadsky - Weizmann Institute of Science, Rehovot, Israel )
7 Aug 2014

Melanoma live: Making patient-focused therapy decisions

Prof Dirk Schadendorf; Dr Paul Nathan; Prof Georgina Long
Melanoma live: Making patient-focused therapy decisions ( Prof Dirk Schadendorf; Dr Paul Nathan; Prof Georgina Long )
1 Aug 2014

ReDO project finds ways of repurposing generic drugs as beneficial cancer treatments

Dr Pan Pantziarka - Anticancer Fund, Brussels, Belgium
ReDO project finds ways of repurposing generic drugs as beneficial cancer treatments ( Dr Pan Pantziarka - Anticancer Fund, Brussels, Belgium )
10 Jul 2014

Repurposing generics to fight cancer and the work of the ReDO Project

Dr Gauthier Bouche - Anticancer Fund, Strombeek-Bever, Belgium
Repurposing generics to fight cancer and the work of the ReDO Project ( Dr Gauthier Bouche - Anticancer Fund, Strombeek-Bever, Belgium )
10 Jul 2014

Looking for biomarkers in metronomic chemotherapy

Prof Guido Bocci - University of Pisa, Pisa, Italy
Looking for biomarkers in metronomic chemotherapy ( Prof Guido Bocci - University of Pisa, Pisa, Italy )
10 Jul 2014

Metronomics and low/middle income countries, especially in breast cancer

Dr Alexandru Eniu - Cancer Institute Ion Chiricuta Cluj-Napoca, Cluj-Napoca, Romania
Metronomics and low/middle income countries, especially in breast cancer ( Dr Alexandru Eniu - Cancer Institute Ion Chiricuta Cluj-Napoca, Cluj-Napoca, Romania )
10 Jul 2014

Continual low-dose metronomic chemotherapy as potentially preferable to aggressive strategies

Prof Yuval Shaked - Israel Institute of Technology, Haifa, Israel
Continual low-dose metronomic chemotherapy as potentially preferable to aggressive strategies ( Prof Yuval Shaked - Israel Institute of Technology, Haifa, Israel )
10 Jul 2014

Quality of life and cost advantages of metronomics and drug repurposing

Dr Lisa Hutchinson - Editor of Nature Reviews, London, UK
Quality of life and cost advantages of metronomics and drug repurposing ( Dr Lisa Hutchinson - Editor of Nature Reviews, London, UK )
10 Jul 2014

Drug repurposing as an alternative to costly drugs such as herceptin in breast cancer

Dr Shripad Banavali - Tata Memorial Hospital, Mumbai, India
Drug repurposing as an alternative to costly drugs such as herceptin in breast cancer ( Dr Shripad Banavali - Tata Memorial Hospital, Mumbai, India )
10 Jul 2014

Benefits of metronomic chemotherapy and the aims of the Metronomic Global Health Initiative

Dr Nicolas André - Hôpital pour Enfants de La Timone, Marseille, France
Benefits of metronomic chemotherapy and the aims of the Metronomic Global Health Initiative ( Dr Nicolas André - Hôpital pour Enfants de La Timone, Marseille, France )
10 Jul 2014

Cost-effectiveness of metronomic approach to neuroblastoma and its use in combination with other therapies

Dr Jaroslav Sterba - University Children’s Hospital Brno, Brno, Czech Republic
Cost-effectiveness of metronomic approach to neuroblastoma and its use in combination with other therapies ( Dr Jaroslav Sterba - University Children’s Hospital Brno, Brno, Czech Republic )
10 Jul 2014

New metronomic approach to neuroblastoma

Prof Frank Berthold - University Hospital Köln, Köln, Germany
New metronomic approach to neuroblastoma ( Prof Frank Berthold - University Hospital Köln, Köln, Germany )
10 Jul 2014